文献速递其他结缔组织病

系统性硬化症中小肠细菌过度生长的治疗:一项系统综述

Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

该系统综述检索了MEDLINE、EMBASE和Cochrane图书馆建库至2017年1月1日的文献,评估系统性硬化症(SSc)患者中小肠细菌过度生长(SIBO)所有可能治疗方案的证据。共纳入5项非随机研究、78例SSc合并SIBO患者,涉及奥曲肽、环丙沙星、利福昔明、诺氟沙星、甲硝唑及阿莫西林联合方案。数据提示抗生素可使部分SSc患者的SIBO得到根除,但研究质量普遍较低且多数为无对照研究,关于促动力药或益生菌疗效的数据匮乏。

要点

  • 共纳入5项非随机研究、78例SSc合并SIBO患者,研究质量普遍较低且多数无对照。
  • 数据提示抗生素可使部分SSc患者的SIBO得到根除。
  • 关于促动力药或益生菌在SSc中的疗效,现有数据匮乏。

核心结论

  • 数据提示,对于部分SSc患者,抗生素可根除SIBO。
  • 关于促动力药或益生菌在SSc中的疗效,现有数据匮乏。

研究设计与样本

  • 系统综述,检索MEDLINE、EMBASE和Cochrane图书馆建库至2017年1月1日的文献。
  • 纳入所有可能SIBO治疗(包括抗生素、促动力药、益生菌和替代治疗)的证据,结局为症状缓解或SIBO根除证据。
  • 共纳入5项非随机研究,合计78例SSc合并SIBO患者。

主要发现

  • 1项试验评估奥曲肽,其余4项试验分别评估环丙沙星、利福昔明、诺氟沙星和甲硝唑,以及阿莫西林、环丙沙星和甲硝唑联合方案的有效性。
  • 研究质量普遍较低,且多数为无对照研究。
  • 数据提示抗生素可使部分SSc患者的SIBO得到根除。

局限性

  • 研究质量普遍较低,且多数为无对照研究。
  • 关于促动力药或益生菌在SSc中的疗效,现有数据匮乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Almost all patients with SSc have gastrointestinal manifestations. Small intestinal bacterial overgrowth (SIBO) occurs in 30-60% of patients and leads to malnutrition and impaired quality of life. Recent systematic reviews have reported efficacy of treatments for SIBO, but these are not specific to patients with SSc. We conducted a systematic review of the evidence for all possible SIBO treatments in the SSc population. METHODS: The following databases were searched: MEDLINE, EMBASE and the Cochrane Library, from database inception to 1 January 2017. All evidence for all possible SIBO treatments including antibiotics, prokinetics, probiotics and alternative treatments was included. Treatment outcomes included symptomatic relief or demonstrated SIBO eradication. RESULTS: Of 5295 articles, five non-randomized studies were reviewed with a total of 78 SSc patients with SIBO. One trial assessed octreotide while the remaining four trials investigated the effectiveness of ciprofloxacin, rifaximin, norfloxacin and metronidazole, and the combination of amoxicillin, ciprofloxacin and metronidazole. Studies were generally of low quality and most were un-controlled. CONCLUSION: Data indicate that, for some SSc patients, antibiotics can eradicate SIBO. There is a paucity of data reporting the effectiveness of either prokinetics or probiotics in SSc.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Pittman N, Rawn SM, Wang M, et al. Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review. Rheumatology (Oxford). 2018. PMID: 29982822. doi:10.1093/rheumatology/key175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。